| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/20/1999 | US5925362 Method to elicit an antitumor response with human prostate-specific antigen |
| 07/20/1999 | US5925361 Ornithobacterium rhinotracheale vaccines |
| 07/20/1999 | US5925360 Isolated dna sequence encoding protein of hog cholera virus or antigenic fragment comprising specified amino acid sequence |
| 07/20/1999 | US5925359 European vaccine strains of the porcine reproductive and respiratory syndrome virus |
| 07/20/1999 | US5925358 Insertion of dna into fowlpox virus genome |
| 07/20/1999 | US5925354 Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae |
| 07/20/1999 | US5925353 Targeted radioimmunotherapy |
| 07/20/1999 | US5925352 Administering antiinflammatory amount of anti-neutrophil chemotactic factor antibodies |
| 07/20/1999 | US5925351 Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 07/20/1999 | US5925347 Viral vector vaccines comprising nucleic acids encoding eimeria proteins for poultry vaccination against coccidiosis |
| 07/20/1999 | CA2155001C Htlv-i and htlv-ii gp21 derived peptides for use in diagnostics |
| 07/20/1999 | CA2137638C Anti gangliosides monoclonal antibodies and their use in the specific active immunotherapy of malignant tumors |
| 07/20/1999 | CA2082394C Pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/20/1999 | CA2053921C Synthetic peptides for an hiv-1 vaccine |
| 07/20/1999 | CA1340665C Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom |
| 07/20/1999 | CA1340656C Membrane anchor/active compound conjugate, its preparation and its use |
| 07/15/1999 | WO1999035271A2 Vibrio cholerae vaccine candidates and method of their constructing |
| 07/15/1999 | WO1999035270A1 Streptococcal heat shock proteins of the hsp60 family |
| 07/15/1999 | WO1999035166A1 Compounds and methods for modulating occludin related tissue permeability |
| 07/15/1999 | WO1999035160A1 Human fk506 binding proteins |
| 07/15/1999 | WO1999035158A1 36 human secreted proteins |
| 07/15/1999 | WO1999034827A1 Activated t-cells and their uses |
| 07/15/1999 | WO1999034826A1 Methods and compositions for desensitisation |
| 07/15/1999 | WO1999034825A1 Fertility impairing vaccine and method of use |
| 07/15/1999 | WO1999034824A2 Tumour vaccines for muc1-positive carcinomas |
| 07/15/1999 | WO1999034823A2 METHODS FOR PREVENTING AND TREATING FIBROTIC DISEASES RESULTING FROM ACCUMULATION OF EXCESS EXTRACELLULAR MATRIX INDUCED BY TGFβ USING RENIN INHIBITORS |
| 07/15/1999 | WO1999034817A1 Agent for treating allergic or hypersensitivity condition |
| 07/15/1999 | WO1999034803A1 Compositions and methods for use in ischemia-reperfusion and endotoxin-related tissue injury |
| 07/15/1999 | WO1999034791A1 Methods and compositions for inactivating viruses |
| 07/15/1999 | WO1999025837A3 Method for producing virus-like particles on the basis of polyoma viruses |
| 07/15/1999 | WO1999025823A3 Recombinant allergen with reduced enzymatic activity |
| 07/15/1999 | WO1999025734A3 Th2 CELL DEPLETION; COMPOSITIONS; METHODS |
| 07/15/1999 | WO1999024466A3 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes |
| 07/15/1999 | WO1999021582A3 Application of tnf antagonists as medicaments for treating septic diseases |
| 07/15/1999 | WO1999018216A9 Chimeric vaccine against tick-borne encephalitis virus |
| 07/15/1999 | WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 07/15/1999 | WO1998055501A9 Improved method for site-selective glycosylation |
| 07/15/1999 | WO1998053066A9 Smad2 phosphorylation and interaction with smad4 |
| 07/15/1999 | WO1998042855A9 Rapid production of autologous tumor vaccines by using hsv amplicon vectors |
| 07/15/1999 | DE19801834A1 New vaccine adjuvant for inoculation of pigs against parvovirus |
| 07/15/1999 | DE19801154A1 Preparation of pure recombinant thyroid stimulating hormone receptor useful for detection of autoantibodies in human serum |
| 07/15/1999 | CA2351624A1 Compounds and methods for modulating tissue permeability |
| 07/15/1999 | CA2318435A1 Human fk506 binding proteins |
| 07/15/1999 | CA2317724A1 Methods and compositions for desensitisation |
| 07/15/1999 | CA2317702A1 36 human secreted proteins |
| 07/15/1999 | CA2317458A1 Methods and compositions for inactivating viruses |
| 07/15/1999 | CA2315880A1 Streptococcal heat shock proteins of the hsp60 family |
| 07/15/1999 | CA2312867A1 Compositions and methods for use in ischemia-reperfusion and endotoxin-related tissue injury |
| 07/15/1999 | CA2296999A1 Activated t-cells and their uses |
| 07/14/1999 | EP0928831A1 Cholera organisms, vaccines and preparation thereof |
| 07/14/1999 | EP0928337A1 A human protein tyrosine kinase |
| 07/14/1999 | EP0928336A1 Chaperone fragments |
| 07/14/1999 | EP0928293A1 Il-6 and il-6-receptor derived peptides having il-6 antagonistic or agonistic activity |
| 07/14/1999 | EP0928199A1 Alkaloid glycoside for use as a medicament |
| 07/14/1999 | EP0928198A2 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis |
| 07/14/1999 | EP0928136A2 Injectable compositions |
| 07/14/1999 | EP0553198B1 Regulation of immunoglobulin production by interleukin-9 |
| 07/14/1999 | EP0531434B1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/14/1999 | CN1222937A Pathogenic escherichia coli associated protein |
| 07/14/1999 | CN1222936A Recombinant protein containing c-terminal fragment of plasmodium MSP-1 |
| 07/14/1999 | CN1222935A Compounds and method for immunotherapy and immunodiagnosis of prostate cancer |
| 07/14/1999 | CN1222917A Novel protein and process for producing the same |
| 07/14/1999 | CN1222914A High molecular weight surface proteins of non-typeable haemophilus |
| 07/14/1999 | CN1222851A Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders |
| 07/14/1999 | CN1222393A Vaccine composition and its preparation |
| 07/14/1999 | CN1044121C Method for isolating coagulation factors VIII complex |
| 07/14/1999 | CN1044092C Antigen-antibody-recombination DNA composite type vaccin |
| 07/13/1999 | US5922853 Human pelota homolog |
| 07/13/1999 | US5922848 Purifying toxin from sample by forming complex with galactose disaccharide covalently bonded through linker arm to support, separating complex from sample, recovering eluted toxin under alkaline, non-denaturing conditions; free of glycolipids |
| 07/13/1999 | US5922847 Exposure to antibody or fragments binding to epitope on receptor recognized by the factor, separating binding cells |
| 07/13/1999 | US5922845 Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies |
| 07/13/1999 | US5922844 Human cAMP-dependent protein kinase inhibitor homolog |
| 07/13/1999 | US5922841 Recombinantly produced transferrin receptor of haemophilus |
| 07/13/1999 | US5922836 Mammaglobin antigens |
| 07/13/1999 | US5922600 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor |
| 07/13/1999 | US5922598 Reducing tissue immunogenicity by induction of apoptosis |
| 07/13/1999 | US5922572 Polynucleotides encoding haemopoietic maturation factor |
| 07/13/1999 | US5922566 Polynucleotide |
| 07/13/1999 | US5922562 Nucleic acids encoding transferrin receptors |
| 07/13/1999 | US5922546 Human disintegrin metalloprotease KUZ gene |
| 07/13/1999 | US5922541 Method for detection of PF4A receptor nucleic acid |
| 07/13/1999 | US5922532 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 07/13/1999 | US5922344 Product for prevention of respiratory virus infection and method of use |
| 07/13/1999 | US5922329 Immunity against giardia from vaccine from isolation of exotoxin |
| 07/13/1999 | US5922328 Herpes simplex |
| 07/13/1999 | US5922327 Equine herpes virus glycoproteins |
| 07/13/1999 | US5922326 Attenuated respiratory syncytial virus vaccine compositions |
| 07/13/1999 | US5922325 Synergistic neutralization of HIV-1 by human monoclonal antibodies and other antibodies directed against the v3 loop and the CD-4 binding site of GP-120,and the use for immunotherapy of HIV-1 infection |
| 07/13/1999 | US5922323 Transferrin receptor genes and immunogenic compositions derived therefrom |
| 07/13/1999 | US5922302 Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 07/13/1999 | US5922253 Production scale method of forming microparticles |
| 07/13/1999 | CA2121257C Stabilised antibodies |
| 07/13/1999 | CA2015828C Canine corona virus vaccine |
| 07/13/1999 | CA1340641C Recombinant lymphotoxin |
| 07/08/1999 | WO1999034217A1 Reagents specific for st2l and uses therefor |
| 07/08/1999 | WO1999034215A1 EXPRESSION AND REFOLDING OF TRUNCATED RECOMBINANT MAJOR OUTER MEMBRANE PROTEIN ANTIGEN (r56) OF ORIENTIA TSUTSUGAMUSHI AND ITS USE IN ANTIBODY BASED DETECTION ASSAYS AND VACCINES |
| 07/08/1999 | WO1999034015A2 Polymorphisms within the rsk-3 gene related to cancer and methods of diagnosis, prognosis, and treatment |
| 07/08/1999 | WO1999034007A1 Delivery of polypeptide-encoding plasmid dna into the cytosol of macrophages by attenuated suicide bacteria |
| 07/08/1999 | WO1999033992A1 Murine intracisternal a particle constitutive transport elements and uses thereof |
| 07/08/1999 | WO1999033981A2 Human signal peptide-containing proteins |